Impact of pH Values of the Embryo Culture Medium on Success of In Vitro Fertilization (IVF) (ACIDOFIV)

Randomized Trial in Assisted Reproductive Technology : Impact of pH Values of the Embryo Culture Medium on Live Birth Rate After In Vitro Fertilization (IVF)

The objective of this study is to compare, through a multicentric randomized trial, the impact of two pH values in the embryo culture medium on the clinical results of In Vitro Fertilization (IVF) process and especially the impact on live birth delivery rate.

Study Overview

• Status: Recruiting
• Conditions: Pregnancy; Humans; Embryo Growth Disorder
• Intervention / Treatment: Procedure: pH at 7.38 ± 0.02; Procedure: pH at 7.22 ± 0.02

Detailed Description

Despite progress in Assisted Reproductive Technology (ART), the livebirth rate per oocyte retrieval during In Vitro Fertilization (IVF) remain relatively low (15 à 25%). This is in part due to the sensitivity of the preimplantation embryo to its environment. Indeed, there is growing evidence that culture conditions during IVF are critical not only for the development of pre- and post-implantation embryo, but also for long-term health effects; and numerous animal data suggest the importance of pH control in the IVF culture medium. Maintaining the intercellular pH (pHi) is one of the vital roles of embryo homeostasis since pHi regulates many cellular processes. Indeed, variations in pHi can affect embryonic development. Although the embryo has biochemical systems to regulate its pHi, these systems can be overtaken. Under the conditions of IVF embryo culture, the extracellular pH (pHe) in a culture medium is the result of a balance between CO2 concentration in the incubator and bicarbonate concentration in the culture medium (determined by the medium manufacturer). The recommendations of the manufacturers of embryo culture media are to maintain a pHe slightly higher (generally between 7.2 and 7.4) than the pHi (estimated between 7.1 to 7.2) to compensate for the acidification due to cell metabolism. However, as the pH scale is logarithmic, a pHe variation of 7.2 to 7.4 corresponds to a decrease in the concentration of H+ ions by a factor of 1.6 in the medium. Actually, there is no clinical data to know what is the ideal pH to apply to a culture medium during IVF.

This is a clinical study comparing two pH values in the culture medium of embryos obtained by IVF, randomized, multicentric (3 centers), patient-blinded, in groups parallel to the ratio 1: 1. IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the oocytes and embryos in the culture medium with a pH at 7.38 ± 0.02 or a pH at 7.22 ± 0.02.

In case of pregnancy after embryo transfer, patients will be followed until delivery.

• Study Type: Interventional
• Enrollment (Estimated): 622
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Nicolas GATIMEL, PH; Phone Number: 33 05 67 77 10 08; Email: gatimel.n@chu-toulouse.fr

Study Locations

• France
  • Bordeaux, France
    • Recruiting
    • CHU de Bordeaux
    • Contact: Aline PAPAXANTHOS, PH; Phone Number: 33 0556795681; Email: aline.papaxanthos@chu-bordeaux.fr
    • Principal Investigator: Aline PAPAXANTHOS, ph
  • Pau, France
    • Recruiting
    • Centre AMP BIOPYRENEES
    • Contact: Steven CENS, ph; Phone Number: 33 0559275131; Email: steven.cens@biopyrenees.com
    • Principal Investigator: Steven CENS, ph
  • Toulouse, France
    • Recruiting
    • CHU de Toulouse
    • Contact: Nicolas GATIMEL, PH; Phone Number: 33 05 67 77 10 08; Email: gatimel.n@chu-toulouse.fr
    • Contact: Célia BETTIOL; Phone Number: 33 05.67.77.13.87; Email: bettiol.c@chu-toulouse.fr
    • Principal Investigator: Nicolas GATIMEL, PH

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Couples whose woman is 18 to 40 years old and man is 18 to 60 at the time of inclusion.
• Infertile couple with a medical indication of IVF-ICSI according to criteria applied in each center.
• First or second ICSI attempt with fresh embryo transfer.
• Signature of informed consent by both partners of the couple
• Affiliation to a social security scheme or equivalent for both partners of the couple.
• Fitting the inclusion criteria for IVF according the the French law.

Exclusion Criteria:

• Use of spermatozoa extracted by testicular biopsy.
• Freeze-al strategy (without fresh embryo transfer) decided before embryo culture
• Absence of mature oocyte (metaphase II) at the day of the puncture
• Uterine pathology affecting implantation (uterine malformation, diffuse adenomyosis ...)
• One of the two partners (or both) is (are) infected with HIV, HCV or HBV in the year before the inclusion
• One of the two partners (or both) is (are) in safeguarding justice, under guardianship or trusteeship.
• Couple having already participated once in the study.
• Couple enrolled in another interventional clinical study

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: pH 7.38 ± 0.02; IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.38 ± 0.02	Procedure: pH at 7.38 ± 0.02; In the 3 centers of the study, IVF-ICSI will be performed according to the usual procedure: ovarian stimulation, oocyte retrieval, sperm microinjection by ICSI, embryo culture in Global® Total HSA medium, embryo selection and transfer at day 3. The day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the embryos in a medium with a pH at 7.38 ± 0.02. We have chosen to study specifically the early stages of fertilization and embryo development (until day 3), stages for which extracellular pH control is more critical because the intracellular pH regulatory mechanisms are somewhat limited and could be exceeded.
Experimental: pH 7.22 ± 0.02; IVF-ICSI will be performed according to the usual procedure and the day of the oocyte puncture, the embryologist will proceed to the culture of the oocytes and embryos in the culture medium with a pH at 7.22 ± 0.02	Procedure: pH at 7.22 ± 0.02; In the 3 centers of the study, IVF-ICSI will be performed according to the usual procedure: ovarian stimulation, oocyte retrieval, sperm microinjection by ICSI, embryo culture in Global® Total HSA medium, embryo selection and transfer at day 3. The day of the oocyte puncture, the embryologist will proceed to the 1: 1 randomization: culture of the embryos in a medium with a pH at 7.22 ± 0.02. We have chosen to study specifically the early stages of fertilization and embryo development (until day 3), stages for which extracellular pH control is more critical because the intracellular pH regulatory mechanisms are somewhat limited and could be exceeded.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Live birth delivery rate	Number of deliveries that resulted in at least one live birth (gestational age ≥ 22 weeks) / Number of oocyte retrievals	month 9

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Fertilization rate	Number of 2PN zygotes at day 1 post-injection / Number of matures injected oocytes	day 1
Cleavage rate	Number of embryos with at least 2 blastomeres at day 2 / Number of diploid zygotes at day 1 post-injection	day 2
Percentage of top embryos	Number of 7 to 10-blastomeres embryos at day 3 with less than 10% fragments / Total number of embryos at day 3	day 3
Embryo freezing rate	Number of frozen embryos / Total number of obtained embryos	day 6
Implantation rate	Number of gestational sacs observed with ultrasonography (5 weeks after embryo transfer) divided by the number of embryos transferred (expressed as a percentage)	week 5
Clinical ongoing pregnancy rate by transfer	Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of embryo transfers	week 5
Clinical ongoing pregnancy rate by oocyte retrieval	Number of pregnancies diagnosed by ultrasonographic of at least one fetus with a discernible heartbeat at 5 weeks after embryo transfer / Number of oocyte retrieval	week 5
Miscarriage rate	Number of spontaneous loss of an intrauterine pregnancy prior to 22 completed weeks of gestational age / Number of pregnancies	week 22
Malformation rate diagnosed at birth	Number of malformations according to Eurocat classification (in total and in Eurocat subgroups) / Total number of newborns	month 9

Collaborators and Investigators

• Sponsor: University Hospital, Toulouse
• Investigators: Principal Investigator: Nicolas GATIMEL, ph, University Hospital, Toulouse

Study record dates

Study Major Dates

• Study Start (Actual): October 14, 2020
• Primary Completion (Estimated): June 1, 2024
• Study Completion (Estimated): April 1, 2025

Study Registration Dates

• First Submitted: June 29, 2020
• First Submitted That Met QC Criteria: June 29, 2020
• First Posted (Actual): July 2, 2020

Study Record Updates

• Last Update Posted (Actual): August 28, 2023
• Last Update Submitted That Met QC Criteria: August 25, 2023
• Last Verified: August 1, 2023

More Information

Terms related to this study

• Keywords: randomized trial; In Vitro Fertilization; pH; live birth rate; embryo culture
• Additional Relevant MeSH Terms: Pathologic Processes; Growth Disorders
• Other Study ID Numbers: RC31/19/0503; 2020-A00221-38 (Other Identifier: ID RCB)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No